ATM-deficient Lung, Prostate and Pancreatic Cancer Cells Are Acutely Sensitive to the Combination of Olaparib and the ATR Inhibitor AZD6738

Genome Instability & Disease
doi 10.1007/s42764-020-00011-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Human Pancreatic Cancer Stem Cells Are Sensitive to Dual Inhibition of IGF-IR and ErbB Receptors

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

The PARP Inhibitor AZD2281 (Olaparib) Induces Autophagy/Mitophagy in BRCA1 and BRCA2 Mutant Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

MTOR Inhibitor-Based Combination Therapies for Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Inhibiting the McM8-9 Complex Selectively Sensitizes Cancer Cells to Cisplatin and Olaparib

Cancer Science
Cancer ResearchMedicineOncology
2019English

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

Cancers
Cancer ResearchOncology
2019English

The G2 Checkpoint Inhibitor CBP-93872 Increases the Sensitivity of Colorectal and Pancreatic Cancer Cells to Chemotherapy

PLoS ONE
Multidisciplinary
2017English

Synergistic Activities of MET/RON Inhibitor BMS-777607 and mTOR Inhibitor AZD8055 to Polyploid Cells Derived From Pancreatic Cancer and Cancer Stem Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

The Combination of Olaparib and Camptothecin for Effective Radiosensitization

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy